Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Spellberg

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
The New England Journal of Medicine|July 3, 1999
Mechanism of intravenous immune globulin therapyB Spellberg
Life Sciences|September 19, 2000
The cutaneous citadel: a holistic view of skin and immunityB Spellberg
Clinical Pharmacology and Therapeutics|July 25, 2014
Prioritized current unmet needs for antibacterial therapiesB Spellberg, D Shlaes
Hematology/Oncology Clinics of North America|November 30, 1999
Autologous bone marrow transplantation in acute leukemiaB Spellberg, G J Schiller
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 19, 2000
Type 1/Type 2 immunity in infectious diseasesB Spellberg, J E Edwards
Clinical Pharmacology and Therapeutics|September 15, 2016
Regulatory Pathways for New Antimicrobial Agents: Trade-offs to Keep the Perfect From Being the Enemy of the GoodB Spellberg, K A Marr, E P Brass
Archives of Internal Medicine|December 1, 2001
mtDNA disease in the primary care settingB Spellberg, R M Carroll, E Robinson, et al.
Infection and Immunity|November 1, 1995
Reduced virulence of Candida albicans PHR1 mutantsM A Ghannoum, B Spellberg, S M Saporito-Irwin, et al.
Infection|June 15, 2007
Societal costs versus savings from wild-card patent extension legislation to spur critically needed antibiotic developmentB Spellberg, L G Miller, M N Kuo, et al.
The Journal of Clinical Investigation|January 15, 1997
Interferon-gamma differentially regulates interleukin-12 and interleukin-10 production in leprosyD H Libraty, L E Airan, K Uyemura, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
The New England Journal of Medicine|July 3, 1999
Mechanism of intravenous immune globulin therapyB Spellberg
Life Sciences|September 19, 2000
The cutaneous citadel: a holistic view of skin and immunityB Spellberg
Clinical Pharmacology and Therapeutics|July 25, 2014
Prioritized current unmet needs for antibacterial therapiesB Spellberg, D Shlaes
Hematology/Oncology Clinics of North America|November 30, 1999
Autologous bone marrow transplantation in acute leukemiaB Spellberg, G J Schiller
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 19, 2000
Type 1/Type 2 immunity in infectious diseasesB Spellberg, J E Edwards
Clinical Pharmacology and Therapeutics|September 15, 2016
Regulatory Pathways for New Antimicrobial Agents: Trade-offs to Keep the Perfect From Being the Enemy of the GoodB Spellberg, K A Marr, E P Brass
Archives of Internal Medicine|December 1, 2001
mtDNA disease in the primary care settingB Spellberg, R M Carroll, E Robinson, et al.
Infection and Immunity|November 1, 1995
Reduced virulence of Candida albicans PHR1 mutantsM A Ghannoum, B Spellberg, S M Saporito-Irwin, et al.
Infection|June 15, 2007
Societal costs versus savings from wild-card patent extension legislation to spur critically needed antibiotic developmentB Spellberg, L G Miller, M N Kuo, et al.
The Journal of Clinical Investigation|January 15, 1997
Interferon-gamma differentially regulates interleukin-12 and interleukin-10 production in leprosyD H Libraty, L E Airan, K Uyemura, et al.
Pageof 2